摘要
Oxysterols是多向性的使者与多个受体系统交互。的同源受体之一oxysterols EBI2,G protein-coupled受体高表达的细胞免疫系统。这里我们讨论的受体在适应免疫和炎症中扮演的角色以及受体的表达和功能与专注于星形胶质细胞在中枢神经系统。我们也讨论oxysterol-producing酶的表达和信号如CH25H和CYP7B1在中枢神经系统和免疫系统。这些步骤将有助于阐明生理的可能的作用途径中枢和周围神经系统和人类疾病的可能联系。
关键词: 星形胶质细胞.自身免疫. 中枢神经系统. EBI2.免疫系统. 神经退化. 少突胶质细胞
图形摘要
Current Drug Targets
Title:The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems
Volume: 17 Issue: 16
Author(s): Aleksandra Rutkowska, Kumlesh K. Dev, Andreas W. Sailer
Affiliation:
关键词: 星形胶质细胞.自身免疫. 中枢神经系统. EBI2.免疫系统. 神经退化. 少突胶质细胞
摘要: Oxysterols are pleiotropic messengers interacting with multiple receptor systems. One of the cognate receptors for oxysterols is EBI2, a G protein-coupled receptor highly expressed in the cells of the immune system. Here we discuss the receptor’s role in the adapted immunity and inflammation as well as the receptor’s expression and function in the CNS with the focus on astrocytes. We also discuss expression and signalling of oxysterol-producing enzymes such as CH25H and CYP7B1 in the CNS and the immune system. These steps will help to elucidate a possible role for this pathway in the physiology of the central and peripheral nervous system and its possible link to human disease.
Export Options
About this article
Cite this article as:
Aleksandra Rutkowska, Kumlesh K. Dev, Andreas W. Sailer , The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems, Current Drug Targets 2016; 17 (16) . https://dx.doi.org/10.2174/1389450117666160217123042
DOI https://dx.doi.org/10.2174/1389450117666160217123042 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Naphthalimides and Azonafides as Promising Anti-Cancer Agents
Current Medicinal Chemistry HSP90 Inhibitors: Multi-Targeted Antitumor Effects and Novel Combinatorial Therapeutic Approaches in Cancer Therapy
Current Medicinal Chemistry Role of miR-193a in Cancer: Complexity and Factors Control the Pattern of its Expression
Current Cancer Drug Targets World Health Organization Classification of Myelodysplastic Syndromes
Current Pharmaceutical Design Resveratrol in Cancer: Cellular and Mitochondrial Consequences of Proton Transport Inhibition
Current Pharmaceutical Design Expression of P-gp, MRP, LRP, GST-π and TopoIIα and Acquired Resistance to Cisplatin in Human Lung Adenocarcinoma Cells
Letters in Drug Design & Discovery Exploring Confluence-Related Signalling to Modulate the Expression of Oct4 – A Role in Facilitating Mouse Somatic Cell Reprogramming?
Current Stem Cell Research & Therapy Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia
Current Drug Targets Synthesis of Novel Coumarin Derivatives 7,8-Fused onto Thiazole
Letters in Organic Chemistry Retroviral Gene Therapy: Safety Issues and Possible Solutions
Current Gene Therapy Advances in Stem Cell Therapy for Leukemia
Current Stem Cell Research & Therapy Large-Scale Production Means for the Manufacturing of Lentiviral Vectors
Current Gene Therapy Biological Activities of Yarrow Species (Achillea spp.)
Current Pharmaceutical Design Pulmonary Arterial Hypertension
Current Vascular Pharmacology Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)
Current Topics in Medicinal Chemistry Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
Current Medicinal Chemistry New Drugs, Therapeutic Strategies, and Future Direction for the Treatment of Pulmonary Arterial Hypertension
Current Medicinal Chemistry Notch-Associated MicroRNAs in Cancer
Current Drug Targets How Much Gets there and What Does it Do?: The Need for Better Pharmacokinetic and Pharmacodynamic Endpoints in Contemporary Drug Discovery and Development
Current Pharmaceutical Design Na+-H+ Exchanger, pH Regulation and Cancer
Recent Patents on Anti-Cancer Drug Discovery